WILSON TROY EDWARD sold 19.9% of their position (10.80K shares) of PUMA BIOTECHNOLOGY, INC. on the open market
Open‑market sale worth $36.7K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/17/2025ACC: 0001437749-25-020721
Director
Since Jun 2019
-10.80K
Net shares
Net seller
$36.7K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
10.80K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−10.80K
Price / share
$3.40
Trade value
$36.72K
% of position
19.9%
6/13/2025
54.35K→43.55K
Total
Net shares
−10.80K
Net value
-$36.72K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/13/2025 | S · Sale | −10.80K | $3.40 | $36.72K | 19.9% | 54.35K | 43.55K |
| Total | −10.80K | -$36.72K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned400.00
Common Stock
IndirectShares owned150.00
Total
550.00 indirect550.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 400.00 | Indirect |
| Common Stock | 150.00 | Indirect |
| Total | 550.00 | 550.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported